END (PPT) Flashcards

(47 cards)

1
Q

act to increase or decrease metabolic processes of cells

A

Hormone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

known as master switchboard of neuroendocrine

A

Hypothalamus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

excess levels of gh

A

Gigantism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

thickening of bony surfaces

A

Acromegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

binds to gh receptor but doesnt stimulate IGF-1 secretion

A

Pegvisomant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

pegvisomant is administered by

A

Subcutaneously

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

inhibits release of GH, glucagon, insulin and gastrin

A

Somastotin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

reduces symptoms caused by hormone secreting tumors

A

Octreotide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ADH is also known as

A

Vasopressin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

stimulates milk ejection

A

Oxytocin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

results from insufficient ADH

A

Diabetes Insipidus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

a diabetes insipidus for nocturnal enuresis, hemophilia

A

Desmopressin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

inner layer of AG

A

Adrenal medulla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what gland secretes norepinephrin and epinephrine into circulation

A

Adrenal Medulla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what gland produces glucocorticoids and mineralocorticoids

A

Adrenal cortex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what do u call the rise and fall of CRH and ACTH

A

Diurnal rhythm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

target and bind receptors responsible for inflammatory and immunosupresive effects

A

Glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

indicated for short term treatment of inflammatory idorders

A

glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

glucocorticoids adverse effects on children:

A

growth retardation

20
Q

increases sodium reabsorption; increase potassium

A

Mineralocorticoids

21
Q

lack of thyroids hormone in infant

22
Q

sever lack of thyroid hormone in adults

23
Q

manmade thyroid hormone t4

A

Levothyroxine

24
Q

what disease is incorporated with hyperthyroidism

A

Graves disease

25
new bone replacses oldbone tissue
Pagets disease
26
drugs preventing loss of bone density
Bisphosphonates
27
hormone regulating levels of calcium and phosphate
Calcitonin
28
increased hunger; cells cant use glucose
Polyphagia
29
loss of fluid and increased tonicity of blood
Polydipsia
30
heart attacks and strokes
Atheroscleoris
31
loss of vision
Retinipathy
32
MOTOR, SENSORY CHANGES IN FEET AND LEGS
Neuropathies
33
Renal dysfunction
Nephropathy
34
condition when body can produce enough insulin
Diabetic ketoacidosis
35
blood sugar below 40mg
Hypoglycemia
36
Types of insulin: Injected at start of a meal
Rapid acting
37
Types of insulin: injected 15-30 mins before a meal
Short-acting
38
Types of insulin: control glucose between meals
Intermediate/longacting
39
Types of insulin: once daily taken
Long acting
40
bind to potassium channels on pancreatic beta cells increase insulin secretion
Sulfonylureas
41
Examples of sulfonylureas:
Glimepiride (Amaryl) Glyburide (DiaBeta; Micronase) Glipizide (Glucotrol)
42
decrease blood glucose
Insulin
43
increase blood glucose
Glucagon
44
decrese insulin sensitivity; increase FFA formation
Growth hormone
45
increase insulin release; stimulate satiety center
incretins
46
increase glucose output from live and muscles; breakdown of fat to FFA
Catecholamines
47
blocks satiety signals; decr adiponectic release; increase fat synthisi, alter gastric motility
Endocannabinoid system